Home » Topics » Regulatory

Regulatory
RSS

Trelagliptin gains first approval in Japan

March 27, 2015

FDA approves Emergent BioSolutions' Anthrasil for treatment of inhalational anthrax

March 26, 2015

FDA approves Unituxin for pediatric patients with high-risk neuroblastoma

March 11, 2015

FDA approves Cresemba for invasive aspergillosis and invasive mucormycosis

March 9, 2015

FDA approves Opdivo for metastatic squamous NSCLC

March 5, 2015

Prevenar 13 approved in E.U. for prevention of pneumococcal pneumonia in adults

March 4, 2015

FDA approves Avycaz for cIAI and cUTI

Feb. 26, 2015

FDA approves Novartis's panobinostat for multiple myeloma

Feb. 24, 2015

FDA approves Dymista for use in children with seasonal allergic rhinitis

Feb. 24, 2015

First stem cell-based medicinal product approved in Europe

Feb. 23, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...